Envision Healthcare: Dual-Silo Chapter 11 Reorganization
ElevenFlo ·
Envision’s 2023 reorganization plans are effective, and reorganized debtor ED Solutions is continuing to reconcile claims. The court’s sixth extension order Dkt. 618 sets May 3, 2027, as the claims reconciliation deadline.
Jump to section
Envision Healthcare Corporation, one of the largest physician staffing companies in the United States, filed chapter 11 petitions on May 15, 2023, in the U.S. Bankruptcy Court for the Southern District of Texas. The filing followed a $9.9 billion leveraged buyout Dkt. 321 by KKR in 2018 that left the company with more than $8 billion in combined debt across two separately capitalized silos. The debtors cited COVID-19, the federal No Surprises Act, and payor reimbursement reductions as factors that reduced revenue against that debt load over the following four years.
The case proceeded as a pre-arranged dual-track reorganization, with separate plans for the AmSurg ambulatory surgery center business and the Envision Physician Services (EVPS) staffing operation. Both plans were confirmed on October 11, 2023 Dkt. 1688, and the reorganized entities emerged on November 3, 2023 Dkt. 1807 -- approximately 172 days after filing. The restructuring eliminated billions in funded debt, converted second-tier secured claims into reorganized equity in each silo, and resolved contested liability management transactions through negotiated plan releases.
| Debtor(s) | Envision Healthcare Corporation (approximately 200+ jointly administered entities in two silos) |
| Court | U.S. Bankruptcy Court, Southern District of Texas (Houston Division) |
| Case Number | 23-90342 |
| Petition Date | May 15, 2023 |
| Confirmation Date | October 11, 2023 |
| Effective Date | November 3, 2023 |
| Judge | Hon. Christopher M. Lopez |
| Claims Agent | Kroll Restructuring Administration LLC |
Table: Case Snapshot
From KKR Buyout to chapter 11
KKR acquired Envision in 2018 for approximately $9.9 billion modernhealthcare.com: Envision Healthcare files for Chapter 11 bankruptcy (outside source), combining EVPS's physician staffing platform with AmSurg's ambulatory surgery center network. At the time of filing, Envision was a multispecialty provider group delivering clinical and management services across emergency departments, surgical suites, intensive care units, and birthing suites, with thousands of dedicated clinicians operating across the country. The resulting debt load -- split between the AmSurg silo ($3.2 billion in funded debt) and the Envision/EVPS silo ($5.45 billion in term loans plus $938.9 million in senior unsecured notes) -- created what the debtors later described as an "insurmountable mismatch" between cash generation and fixed obligations.
The No Surprises Act. Effective January 1, 2022, the federal No Surprises Act ended balance billing of out-of-network patients. Envision contended that the implementing regulations created a rebuttable presumption favoring insurers' Qualifying Payment Amounts in arbitration, generating approximately $180 million in lost revenue Dkt. 321 in 2022. As of the petition date, the backlogged federal arbitration system had processed only 107,000 of 335,000 initiated disputes.
Payor reimbursement reductions. Envision's largest payor reduced total reimbursements by nearly 60% over five years Dkt. 321, resulting in more than $400 million of revenue decline. The debtors cited arbitrarily changed contract terms ($100 million impact in 2018), extracted rate reductions ($100 million in 2019), and systematic denial of payment on more than 35% of emergency medicine claims since 2021, costing approximately $50 million per year. Total underpayment of claims by that payor exceeded $200 million Dkt. 321.
COVID-19 and labor costs. The pandemic reduced revenues by approximately $1.1 billion Dkt. 321 in 2020 and EBITDA by approximately $415 million, with an additional $380 million revenue impact in 2021. The pandemic response also delayed the company's operational transformation and cost rationalization efforts. Concurrently, a nationwide healthcare labor shortage drove medical hospital labor expenses up by more than 25% over the three years preceding the filing, with clinician wage and premium labor increases totaling approximately $330 million annually compared to 2019 levels. General inflation further increased the cost of equipment and supplies for the ASC business Dkt. 321.
Capital Structure and Dual-Silo Architecture
The debtors maintained two legally distinct, separately capitalized debt structures. The AmSurg entities were designated as Unrestricted Subsidiaries under the Envision-level credit facilities -- a designation that became central to the contested liability management transactions.
AmSurg silo. The AmSurg Debtors carried approximately $3.2 billion Dkt. 321 in aggregate funded debt at filing:
| Facility | Outstanding | Maturity |
|---|---|---|
| Revolving Credit Facility | $301 million | July 2026 |
| First Lien Term Loan | $1,358 million | April 2027 |
| Second Lien Term Loan | $1,494 million | April 2028 |
Table: AmSurg Funded Debt at Petition Date
AmSurg LLC had also extended approximately $1.8 billion Dkt. 321 (including accrued interest) in senior secured intercompany term loans to Envision Healthcare Corporation, split between short-term ($984 million) and long-term ($849 million) tranches.
Envision/EVPS silo. The EVPS-level debt included an ABL facility with up to $550 million in borrowing capacity, a $5.45 billion term loan facility divided into first-out, second-out, third-out, and fourth-out tranches following the 2022 restructuring transactions, and approximately $938.9 million in unsecured senior notes Dkt. 1230. Credit Suisse AG served as administrative and collateral agent for the Envision first lien credit facilities.
Drop Down, Up-Tier, and LME Challenges
The 2022 prepetition liability management exercises generated adversary proceedings and a UCC standing motion.
The Drop Down Transaction (April 2022). AmSurg LLC entered into a new first lien credit agreement securing approximately $1.3 billion in commitments Dkt. 321 and distributed approximately $1.1 billion of the proceeds to Envision. The board then designated AmSurg Holdco and its subsidiaries as Unrestricted Subsidiaries under the existing 2018 debt instruments, releasing them from those facilities' obligations and liens.
The Up-Tier Transaction (June--August 2022). AmSurg secured an additional approximately $1.3 billion in second lien debt, which was loaned to Envision. Envision used the proceeds to repurchase approximately $1.903 billion Dkt. 321 of existing debt at a discount, capturing approximately $582 million in discount and approximately $90 million in interest savings. Participating lenders received amended terms including priority of recovery and maturity extensions. KKR held term loans in the tranches created by the Up-Tier Transaction. Lenders who did not participate were relegated to "fourth-out" (last-in-line) status.
The debtors retained an Independent Director, Gary D. Begeman, with Haynes and Boone LLP as counsel, to investigate the LME transactions. On September 15, 2023, the Independent Director concluded Dkt. 1646 that the transactions provided approximately $1.7 billion in quantified benefits to the company, that the board acted in accordance with its fiduciary duties, and that no evidence of actual fraud was found. He further concluded that the plan release provisions were in the best interests of all parties.
UCC standing motion. The Official Committee of Unsecured Creditors filed a motion on August 17, 2023 Dkt. 1358 seeking standing to commence an adversary proceeding to avoid the prepetition LME transactions as actual and constructive fraudulent transfers under Section 548 and New York state law. The Committee challenged the validity of prepetition liens and contested the proposed release of secured parties without consideration, noting the debtors produced 50,000 documents in the final five days of the challenge period. The dispute was resolved through plan negotiations and the confirmation releases.
Crescent Capital / Vibrant Capital adversary proceeding. Vibrant Capital Partners, Vibrant Credit Partners, Saratoga Investment Corp. CLO 2013-1 Ltd., and Crescent Capital Group LP filed an adversary proceeding Dkt. 1155 on July 31, 2023, alleging breach of contract and breach of the implied covenant of good faith and fair dealing. The plaintiffs claimed the April 2022 Drop Down and Up-Tier Transactions violated the "Sacred Rights" provision (Section 13.1) of the original credit agreement, which required unanimous consent for actions reducing principal, extending maturity, or releasing collateral. The proceeding was voluntarily dismissed with prejudice Dkt. 20 on November 9, 2023, following the effective date.
RSA, Cash Collateral, and UCC Objections
The debtors did not obtain DIP financing. Envision filed simultaneously with a Restructuring Support Agreement already in place and operated under consensual cash collateral arrangements. Separate RSAs governed the AmSurg and EVPS debtors. The AmSurg RSA was supported by the Consenting AmSurg RCF Lenders, the Consenting AmSurg First Lien Term Lenders, and the Consenting AmSurg Second Lien Term Lenders. The EVPS RSA was supported by Consenting EVPS Initial Term Loan Lenders and other EVPS term loan lender classes.
The court entered a Final AmSurg Cash Collateral Order Dkt. 492 on June 29, 2023, authorizing use of AmSurg cash collateral with adequate protection liens and claims for the prepetition secured parties. A separate EVPS Cash Collateral Order Dkt. 489 similarly provided adequate protection for EVPS term lenders and ABL lenders. The Official Committee of Unsecured Creditors filed objections Dkt. 425 to the cash collateral orders, contesting aspects of the secured lenders' adequate protection arrangements. The UCC also filed a separate objection to the allowance of AmSurg First Lien Term Loan Claims Dkt. 1169 on August 1, 2023, contesting the validity, extent, and priority of those liens.
Dual-Track Plan Treatment, Exit Financing, and Emergence
The case produced two separate confirmed plans -- an AmSurg Plan and an EVPS Plan -- each addressing its respective debt silo. Plan treatment was outlined in the Solicitation Motion Dkt. 482 filed June 29, 2023. The court approved the disclosure statements on August 2, 2023, and set a general bar date for non-governmental creditors of August 7, 2023. Publication notice of the bar date was issued in The New York Times on July 12, 2023 Dkt. 1807. The confirmation hearing was held over two days on October 9--10, 2023.
AmSurg Plan. The AmSurg RCF claims ($301 million) and first lien term loan claims ($1,358 million) were paid in full in cash Dkt. 482, with the first lien repaid from exit term loan proceeds. The AmSurg second lien term loan holders ($1,494 million) received 100% of the reorganized equity in Reorganized AmSurg Parent plus subscription rights through a backstop commitment agreement and an equity rights offering Dkt. 1688 (ERO). The plan also incorporated an EHC ASC Debtors Sale Transaction involving the sale of certain ambulatory surgery center assets of Envision-affiliated entities into the reorganized AmSurg structure. General unsecured creditors received a pro rata share of $1.5 million in cash. Intercompany claims and interests were reinstated, settled, or released without distribution, and interests in AmSurg Parent were cancelled without distribution.
EVPS Plan. EVPS ABL claims were paid in full in cash or received revolving commitments under an amended ABL facility. EVPS first-out term loan claims received a pro rata share of the First-Out Cash Payment and, if applicable, exit term loans Dkt. 1603. The EVPS second-out term loan holders received 100% of the reorganized equity Dkt. 482 in Reorganized Envision Parent. Holders of approximately $938.9 million in EVPS unsecured senior notes received three-year warrants issued on the effective date if the class voted to accept -- otherwise no recovery. Intercompany loan claims ($1.833 billion including accrued interest owed by Envision to AmSurg) were cancelled and extinguished without distribution under the EVPS Plan. General unsecured creditors received a pro rata share of $1 million if the class accepted. Equity interests in Envision Parent were cancelled without distribution.
| Plan | Senior Secured | Second-Tier Secured | Unsecured Notes | GUC | Equity |
|---|---|---|---|---|---|
| AmSurg | 100% cash | Reorganized equity + subscription rights | N/A | $1.5M pool | Cancelled |
| EVPS | 100% cash / exit loans | Reorganized equity | Warrants (if accepting) | $1M pool (if accepting) | Cancelled |
Table: Plan Recovery Summary
Both plans contained third-party release provisions with opt-out mechanisms for holders of claims. The EVPS and AmSurg Confirmation Orders confirmed the injunction, release, and exculpation provisions.
AmSurg exit facilities. The reorganized AmSurg entities secured an exit first lien term loan Dkt. 1688 facility of approximately $1.6 billion, an exit revolving credit facility of approximately $300 million, and approximately $45 million in ASC-level debt.
EVPS exit facilities. The reorganized EVPS entities entered into an amended and restated ABL facility and EVPS exit term loans Dkt. 1603.
Both plans became effective on November 3, 2023 Dkt. 1807. The restructuring eliminated approximately $7 billion in debt reuters.com: Bankrupt Envision Healthcare approved to split in two, cut debt (outside source) across both silos, and KKR relinquished ownership of both resulting entities. On emergence, the reorganized entities separated into distinct businesses: Reorganized AmSurg Parent (ambulatory surgery centers) and Reorganized Envision Parent (physician staffing and services).
Professional Retentions and Post-Emergence Claims Activity
First-day retention applications were filed on June 14, 2023, for the debtors' principal advisors. PJT Partners LP served as investment banker to the debtors, requesting total fees of $42.6 million Dkt. 1922, including a net restructuring fee of $27.5 million (after credits) and capital raising fees of $13.9 million. The capital raising fees comprised an EVPS DIP Financing Fee of $908,480, an AmSurg ERO/Rights Offering Fee of $9 million Dkt. 1922, and an EVPS Exit Financing Fee of $4 million. Kirkland & Ellis LLP served as lead bankruptcy counsel, requesting $17.8 million Dkt. 1937 in fees for the period from petition through confirmation. Jackson Walker LLP served as local co-counsel, with a final application of $69,893 Dkt. 1928.
Alvarez & Marsal North America LLC served as financial advisor to the debtors, with cumulative fees of approximately $3.7 million Dkt. 1931 through September 2023. White & Case LLP served as counsel to the Official Committee of Unsecured Creditors ($3.1 million Dkt. 1858 through September 2023), and Piper Sandler & Co. Dkt. 1338 was retained as the Committee's financial advisor by order dated August 15, 2023. Kroll Restructuring Administration LLC earned approximately $2.6 million Dkt. 1893 through September 2023 as claims and noticing agent. Haynes and Boone LLP served as counsel to the Independent Director ($652,000 Dkt. 1926), Force Ten Partners LLC served as financial advisor to the Independent Director and EVPS ($1.6 million Dkt. 1873), and KPMG LLP provided tax and other professional services with cumulative fees of approximately $869,000 Dkt. 1783 through September 2023.
Post-effective date claims activity. The debtors filed a First Omnibus Objection Dkt. 1906 followed by sixteen or more subsequent omnibus objections addressing no-liability, duplicative, amended, and equity claims. UnitedHealthcare administrative expense claims were resolved through a stipulation and agreed order Dkt. 10 in January 2024. Post-confirmation, UnitedHealthcare Services and affiliated entities had filed motions Dkt. 1741 seeking relief from the automatic stay to assert setoff rights in prepetition litigation.
In December 2023, the court ruled in a contested matter that a debtor's non-economic managerial and voting rights in an LLC constitute property of the bankruptcy estate protected by the automatic stay, overriding conflicting Delaware state law that attempted to strip such rights upon a chapter 11 filing. The ruling addressed AmSurg Holdings, LLC's retained governance rights in the Folsom Endoscopy Center.
In January 2026, the court approved a stipulation granting limited stay relief for insurance-funded medical malpractice litigation (the Bain Action Dkt. 567) to proceed in Louisiana. A separate adversary proceeding was filed Dkt. 379 by Dr. Hani Hanna in April 2025 regarding nondischargeability, raising the question of whether Dr. Hanna was a "known creditor" entitled to actual notice or an "unknown creditor" served by publication. Claims filed by Michael Asare totaling $5 million were expunged; the court denied reconsideration and enjoined further unauthorized filings, with Asare filing a notice of appeal Dkt. 555 to the U.S. District Court in December 2025.
Separately, the bankruptcy filing triggered an automatic stay on a lawsuit aaem.org: Envision Lawsuit - AAEM (outside source) brought by the American Academy of Emergency Medicine Physician Group alleging that Envision's "Friendly PC" staffing model violated California's corporate practice of medicine laws. A federal bankruptcy court hklaw.com: Federal Bankruptcy Court Stays Envision Healthcare Litigation in California (outside source) stayed that California litigation in August 2023. Envision subsequently exited all operations in California, and the settlement included the non-enforcement of restrictive covenants for physicians.
Frequently Asked Questions
Who is the claims agent for Envision Healthcare?
Kroll Restructuring Administration LLC serves as the claims and noticing agent. The firm maintains the official claims register and distributes case notifications to creditors and parties in interest.
What caused Envision Healthcare's bankruptcy?
The debtors identified the core driver as an "insurmountable mismatch" between cash generation and the debt load resulting from the 2018 KKR acquisition. The debtors also cited the No Surprises Act (approximately $180 million in lost revenue in 2022), a nearly 60% reduction in reimbursements from the company's largest payor over five years, COVID-19 revenue losses exceeding $1.1 billion in 2020, and healthcare labor cost increases of approximately $330 million annually compared to 2019.
What were the liability management transactions?
In 2022, the debtors executed a Drop Down Transaction that moved the AmSurg business into an Unrestricted Subsidiary structure and an Up-Tier Transaction that repurchased approximately $1.9 billion of existing debt at a discount. Non-participating lenders were relegated to fourth-out status. These transactions were challenged by dissident lenders and the UCC but resolved through plan negotiations.
How long was Envision Healthcare in bankruptcy?
Approximately 172 days. The case was filed on May 15, 2023, and both plans became effective on November 3, 2023.
Was there a securities class action settlement?
Yes. A long-standing securities class action regarding Envision's billing practices was stayed during the bankruptcy. After emergence, the parties reached a $177.5 million settlement rgrdlaw.com: Robbins Geller Achieves Historic $177.5 Million Recovery for ... (outside source) fully funded by insurance proceeds, which received final court approval in March 2024.
What happened to Envision's operations after emergence?
On emergence, the reorganized entities separated into two distinct businesses: Reorganized AmSurg Parent (ambulatory surgery centers) and Reorganized Envision Parent (physician staffing and services). The Oregon Health Authority oregon.gov: Oregon Health Authority (outside source) reviewed the restructuring and concluded that the split was unlikely to impact the operations or quality of care at the company's five ambulatory surgery centers in Oregon. A one-year follow-up review oregon.gov: one-year follow-up review (outside source) confirmed that the company largely adhered to its commitments regarding operational and management stability.
For more bankruptcy case coverage, visit the ElevenFlo bankruptcy blog.
Sources
- Dkt. 10Stipulation and Agreed Order Regarding Claimants' Asserted Administrative Expense Claims (Related document: 9 Stipulation). Signed on 1/30/2024.Filed Jan 30, 2024Jan 30, 2024
- Dkt. 20Notice of Voluntary Dismissal With Prejudice Filed by Crescent Capital Group, LP, Saratoga Investment Corp. CLO 2013-1 Ltd., Vibrant Capital Partners, Inc., Vibrant Credit Partners, LLCFiled Nov 9, 2023Nov 9, 2023
- Dkt. 321Witness List, Exhibit List (Filed By Envision Healthcare Corporation ). (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3 # 4 Exhibit 4 # 5 Exhibit 5)Filed Jun 14, 2023Jun 14, 2023
- Dkt. 379Adversary case 25-03123. Nature of Suit: (65 (Dischargeability - other)),(91 (Declaratory judgment)) Complaint by Hani Hanna against Envision Physician Services, LLC, Envision Healthcare Corporation. Fee Amount $350 (Attachments: # 1 Exhibit Exhibit 1- Employment Agreement with Envision # 2 Exhibit Exhibit 2- Amended Complaint filed in District of New Jersey # 3 Exhibit Exhibit 3- May 19 2022 Demand Letter # 4 Exhibit Exhibit 4- June 7 2022 Correspondence # 5 Exhibit Exhibit 5- June 9 2022 Email)Filed Apr 8, 2025Apr 8, 2025
- Dkt. 425Objection of the Official Committee Of Unsecured Creditors To The Debtors Emergency Motion For Entry of Interim and Final Orders (A) Authorizing the Debtors to Use Cash Collateral, and Renew Letters of Credit, (B) Granting Liens and Providing Claims with Superpriority Administrative Expense Status and Adequate Protection to the Prepetition Secured Parties, (C) Modifying the Automatic Stay, (D) Scheduling a Final Hearing, and (E) Granting Related Relief (related document(s):18 Emergency Motion (with hearing date)). Filed by The Official Committee of Unsecured CreditorsFiled Jun 27, 2023Jun 27, 2023
- Dkt. 482Motion for Entry of an Order (I) Approving the Adequacy of the Disclosure Statements, (II) Approving the Solicitation and Notice Procedures with Respect to the Confirmation of the Debtors Proposed Joint Plans of Reorganization, (III) Approving the Forms of Ballots and Notices in Connection Therewith, and (IV) Scheduling Certain Dates with Respect Thereto Filed by Debtor Envision Healthcare Corporation Hearing scheduled for 8/2/2023 at 01:00 PM at Houston, Courtroom 401 (CML). (Attachments: # 1 Proposed Order)Filed Jun 29, 2023Jun 29, 2023
- Dkt. 489Proposed Order Submission After Hearing (Filed By Envision Healthcare Corporation ).(Related document(s):18 Emergency Motion (with hearing date), 105 Generic Order) (Attachments: # 1 Redline)Filed Jun 29, 2023Jun 29, 2023
- Dkt. 492Final Amsurg Cash Collateral Order (re Docket No. 18) Signed on 6/29/2023Filed Jun 29, 2023Jun 29, 2023
- Dkt. 555Notice of Appeal of Claim Objection OrderFiled Dec 11, 2025Dec 11, 2025
- Dkt. 567Stipulation Granting Limited Stay ReliefFiled Jan 12, 2026Jan 12, 2026
- Dkt. 618Claims Deadline ExtendedFiled Oct 16, 2026Oct 16, 2026
- Dkt. 1155Adversary case 23-03140. Nature of Suit: (91 (Declaratory judgment)),(02 (Other (e.g. other actions that would have been brought in state court if unrelated to bankruptcy))) Complaint by Vibrant Capital Partners, Inc., Vibrant Credit Partners, LLC, Saratoga Investment Corp. CLO 2013-1 Ltd., Crescent Capital Group, LP against Envision Healthcare Corporation, Arrowmark Colorado Holdings LLC, Barings LLC, Benefit Street Partners LLC, Black Diamond Credit Strategies Master Fund, Ltd., BlackRock Financial Management, Inc., Blackstone Alternative Credit Advisors LP, BofA Securities, Inc., AS Birch Grove, LP, Brigade Capital Management LP, BroadRiver Asset Management, L.P., Canyon Partners, LLC, Carlyle CLO Management L.L.C., CIFC Asset Management LLC, Columbia Cent CLO Advisors, LLC, Eaton Vance Management, First Eagle Alternative Credit, LLC, First Trust Capital Solutions, L.P., First Trust Advisors, L.P., HPS Investment Partners, LLC, HSBC Americas Corporation (Delaware), Intermediate Capital Group, Inc., Invesco Senior Loan Fund, Irradiant Partners, LP, King Street Capital Management, L.P., Marathon Asset Management, L.P., Mariner Investment Group, LLC, MidOcean Partners, L.P., MJX Asset Management LLC, Napier Park Global Capital (US) LP, Neuberger Berman Investment Advisors LLC, NYL Investors LLC, Oak Hill Advisors, L.P., Octagon Credit Investors, LLC, Palmer Square Capital Management, LLC, PGIM, Inc., PPM Loan Management Company, LLC, Redding Asset Management LLC, Redwood Capital Management, LLC, Sculptor Loan Management LP, Sound Point Capital Management, LP, Strategic Value Partners, LLC, Victory Capital Mgmt, Inc., Voya Alternative Asset Management LLC, Voya Investment Management Co. LLC, Wellfleet Credit Partners LLC. Fee Amount $350Filed Jul 31, 2023Jul 31, 2023
- Dkt. 1169Objection of The Official Committee of Unsecured Creditors to the AmSurg First Lien Term Loan Claims (related document(s) 492, 589) (REDACTED). Filed by The Official Committee of Unsecured CreditorsFiled Aug 1, 2023Aug 1, 2023
- Dkt. 1230Second Amended Disclosure Statement Filed by Envision Healthcare Corporation. (Related document(s):480 Disclosure Statement)Filed Aug 2, 2023Aug 2, 2023
- Dkt. 1338Order Authorizing the Retention and Employment of Piper Sandler & Co. as Investment Banker to the Official Committee of Unsecured Creditors Effective June 29, 2023 (Related Doc # 1090). Signed on 8/15/2023.Filed Aug 15, 2023Aug 15, 2023
- Dkt. 1358Motion / The Official Committee of Unsecured Creditors' Motion for Leave, Standing, and Authority to Commence, Prosecute, and Settle Certain Claims and Causes of Action Relating to the LME Transactions on behalf of the Debtors' Estates (REDACTED) Filed by Creditor Committee The Official Committee of Unsecured Creditors (Attachments: # 1 Exhibit A - Proposed Order # 2 Exhibit B - Proposed Complaint)Filed Aug 17, 2023Aug 17, 2023
- Dkt. 1603Third Amended Chapter 11 Plan Filed by Envision Healthcare Corporation. (Related document(s):479 Chapter 11 Plan) (Attachments: # 1 Redline)Filed Oct 5, 2023Oct 5, 2023
- Dkt. 1646Declaration re: Declaration of Independent Director Gary D. Begeman Concerning Confirmation of the Amended Joint Chapter 11 Plan of Reorganization of the Amsurg Debtors and the Amended Joint Chapter 11 Plan of Reorganization of the EVPS Debtors (Filed By Envision Healthcare Corporation ).Filed Oct 9, 2023Oct 9, 2023
- Dkt. 1688Order Confirming the Third Amended Joint Chapter 11 Plan of Reorganization of the Amsurg Debtors (Technical Modifications) (Related document: 1650 Amended Chapter 11 Plan). Signed on 10/11/2023.Filed Oct 11, 2023Oct 11, 2023
- Dkt. 1741Motion for Relief from Stay / Motion of United Healthcare Services, Inc., UnitedHealthcare Insurance Company and UMR, Inc. for Relief from the Automatic Stay to, Inter Alia, Assert their Setoff and Recoupment Claims, Counterclaims, and Defenses with Respect to Pending Prepetition Litigations with Envision Healthcare Corporation and Envision Physician Services, LLC. Fee Amount $188. Filed by Creditors UMR, Inc., United Healthcare Services, Inc., UnitedHealthcare Insurance Company Hearing scheduled for 11/9/2023 at 01:00 PM at Houston, Courtroom 401 (CML).Filed Oct 23, 2023Oct 23, 2023
- Dkt. 1783Operating Report for Filing Period 9/30/2023, $584,471,992 disbursed (Filed By Envision Healthcare Corporation ).Filed Oct 31, 2023Oct 31, 2023
- Dkt. 1807Notice of (I) Entry of Orders Confirming (A) the Third Amended Joint Chapter 11 Plan of Reorganization of the EVPS Debtors (Technical Modifications) and (B) The Third Amended Joint Chapter 11 Plan of Reorganization of the AmSurg Debtors (Technical Modifications) and (II) Occurrence of the Effective Date. (Related document(s):1687 Order Confirming Chapter 11 Plan, 1688 Order Confirming Chapter 11 Plan) Filed by Envision Healthcare CorporationFiled Nov 3, 2023Nov 3, 2023
- Dkt. 1858Final Application for Compensation for White & Case LLP, Creditor Comm. Aty, Period: 6/2/2023 to 10/11/2023, Fee: $12,034,404.0, Expenses: $119,069.27. Objections/Request for Hearing Due in 21 days. Filed by Attorney White & Case LLPFiled Nov 22, 2023Nov 22, 2023
- Dkt. 1873Final Application for Compensation for Force Ten Partners, LLC, Financial Advisor, Period: 6/2/2023 to 10/11/2023, Fee: $6,554,212.50, Expenses: $33,675.81. Objections/Request for Hearing Due in 21 days. Filed by Financial Advisor Force Ten Partners, LLCFiled Nov 29, 2023Nov 29, 2023
- Dkt. 1893Notice of Fifth and Final Monthly Fee Statement of Alvarez & Marsal North America, LLC for Compensation of Services Rendered and Reimbursement of Expenses as Financial Advisor to the Debtors and Debtors in Possession for the Period from October 1, 2023 through October 11, 2023. Filed by Envision Healthcare CorporationFiled Dec 4, 2023Dec 4, 2023
- Dkt. 1906Objection to Claim Number by Claimant Reorganized Debtors' First Omnibus Objection to Certain Proofs of Claim (Amended Claims, Exact Duplicate Claims, and Fully Satisfied Claims) Hearing scheduled for 1/18/2024 at 01:00 PM at telephone and video conference. (Attachments: # 1 Proposed Order)Filed Dec 8, 2023Dec 8, 2023
- Dkt. 1922Application for Compensation First and Final Fee Application of PJT Partners LP as Investment Banker to the Debtors and Debtors in Possession for the Fee Period From May 15, 2023 Through October 11, 2023. Objections/Request for Hearing Due in 21 days. Filed by Attorney Rebecca Blake Chaikin (Attachments: # 1 Proposed Order)Filed Dec 18, 2023Dec 18, 2023
- Dkt. 1926Application for Compensation First and Final Fee Application of Haynes and Boone, LLP as Counsel for Gary D. Begeman, in His Capacity as an Independent Director, for the Fee Period From May 15, 2023 Through October 11, 2023. Objections/Request for Hearing Due in 21 days. Filed by Attorney Rebecca Blake Chaikin (Attachments: # 1 Proposed Order)Filed Dec 18, 2023Dec 18, 2023
- Dkt. 1928Application for Compensation Second Interim and Final Fee Application of Jackson Walker LLP as Co-Counsel and Conflicts Counsel to the Debtors and Debtors in Possession for the Interim Period From September 1, 2023 Through October 11, 2023 and the Final Period From May 15, 2023 Through October 11, 2023. Objections/Request for Hearing Due in 21 days. Filed by Attorney Rebecca Blake Chaikin (Attachments: # 1 Proposed Order)Filed Dec 18, 2023Dec 18, 2023
- Dkt. 1931Application for Compensation Second Interim and Final Fee Application of Alvarez & Marsal North America, LLC as Restructuring Advisors to the Debtors and Debtors in Possession for the (I) Second Interim Period from September 1, 2023 Through October 11, 2023 and (II) Total Fee Period from May 15, 2023 Through October 11, 2023. Objections/Request for Hearing Due in 21 days. Filed by Attorney Vienna Flores Anaya (Attachments: # 1 Proposed Order)Filed Dec 18, 2023Dec 18, 2023
- Dkt. 1937Application for Compensation Second and Final Fee Application of Kirkland & Ellis LLP and Kirkland & Ellis International LLP, Attorneys for the Debtors and Debtors in Possession, for (I) the Second Interim Fee Period from September 1, 2023 Through and Including October 11, 2023, and (II) the Final Fee Period from May 15, 2023 Through and Including October 11, 2023. Objections/Request for Hearing Due in 21 days. Filed by Attorney Vienna Flores Anaya (Attachments: # 1 Proposed Order)Filed Dec 18, 2023Dec 18, 2023
- WebEnvision Healthcare files for Chapter 11 bankruptcymodernhealthcare.com · Outside source
- WebBankrupt Envision Healthcare approved to split in two, cut debtreuters.com · Outside source
- WebEnvision Lawsuit - AAEMaaem.org · Outside source
- WebFederal Bankruptcy Court Stays Envision Healthcare Litigation in Californiahklaw.com · Outside source
- WebRobbins Geller Achieves Historic $177.5 Million Recovery for ...rgrdlaw.com · Outside source
- WebOregon Health Authorityoregon.gov · Outside source
- Webone-year follow-up revieworegon.gov · Outside source